Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2021 | 06-2021 | 03-2021 | 09-2020 | 06-2020 | |
Sales | 12,769,560 | 0 | 10,712,960 | 11,547,560 | 0 |
Cost of Goods | 3,818,250 | N/A | 3,235,830 | 3,712,427 | N/A |
Gross Profit | 8,951,308 | N/A | 7,477,131 | 7,835,137 | N/A |
Operating Expenses | 5,371,506 | 0 | 4,951,024 | 4,908,639 | 0 |
Operating Income | 3,580,051 | N/A | 2,526,938 | 2,926,924 | N/A |
Interest Expense | 102,590 | 0 | 119,354 | 106,370 | 0 |
Other Income | 3,537 | 0 | -18,084 | 42,082 | 0 |
Pre-tax Income | 3,480,998 | 0 | 2,389,499 | 2,862,636 | 0 |
Income Tax | 718,133 | N/A | 487,062 | 572,761 | N/A |
Net Income Continuous | 2,762,865 | N/A | 1,902,437 | 2,289,875 | N/A |
Minority Interests | 30,659 | N/A | 14,467 | 8,182 | N/A |
Net Income | $2,732,206 | $N/A | $1,887,970 | $2,281,693 | $N/A |
EPS Basic Total Ops | 1.09 | N/A | 0.75 | 0.91 | N/A |
EPS Basic Continuous Ops | 1.10 | N/A | 0.76 | 0.91 | N/A |
EPS Diluted Total Ops | 1.09 | N/A | 0.75 | 0.91 | N/A |
EPS Diluted Continuous Ops | 1.10 | N/A | 0.76 | 0.91 | N/A |
EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | N/A | 0.65 |
EBITDA(a) | $3,580,051 | $N/A | $2,526,938 | $2,926,924 | $N/A |